-
For today's top Money video click here - News Providers
- Associated Press
- Barron's
- bizjournals.com
- Briefing.com
- BusinessWeek
- Business Wire
- Forbes
- GlobeNewswire
- InvestorPlace
- MarketWatch
- Market Wire
- Minyanville
- Motley Fool
- MSNBC
- PRNewswire
- Thomson Reuters
- TheStreet.com
- Wall Street Journal
- News by Topic
- Companies
- Economy
- Industry
- Stock Market
- Commentary
- This Week
- Index
- MSN Money Experts
- Jim Jubak
- Jon Markman
- Liz Pulliam Weston
- MP Dunleavey
- More Experts
BridgePoint Medical receives European approval for devicesNovember 23, 2009 1:04 PM ETMitch Anderson BridgePoint Medical Inc. announced Monday that it has received approval to sell and use its new catheter devices in Europe. The Plymouth-based medical-technology company earned the European CE Mark, the European equivalent of the U.S. Food and Drug Administration’s (FDA) seal of approval, to market its CrossBoss CTO Crossing Catheter and the Stingray CTO Re-Entry System. A recent medical trial showed the products resulted in a greater success rate in allowing doctors to access heavily diseased arteries than the standard guidewires that are now in use. The BridgePoint devices are under clinical investigation in the United States and have yet to receive FDA approval. Copyright 2009 bizjournals.com
|
E-mail this article
Print-friendly version
Discuss this article
- Data providers
- Copyright © 2010 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.